Eliyahu Sharon Kalif
EVP, Chief Financial Officer · 7 filings · Latest: Jun 11, 2026
TEVA PHARMACEUTICAL INDUSTRIES LTD
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TEVA | Eliyahu Sharon Kalif | EVP, Chief Financial Officer | Jun 11, 2026 | Sale | $34.10 | 106,563 | $3.6M | 65,621 | |
TEVA | Kalif Eliyahu Sharon | — | Jun 11, 2026 | Proposed Sale | $34.10 | 106,563 | $3.6M | — | |
TEVA | Eliyahu Sharon Kalif | EVP, Chief Financial Officer | May 14, 2026 | Sale | $35.61 | 153,251 | $5.5M | 172,184 | |
TEVA | Kalif Eliyahu Sharon | — | May 14, 2026 | Proposed Sale | $35.61 | 153,251 | $5.5M | — | |
TEVA | Eliyahu Sharon Kalif | EVP, Chief Financial Officer | Mar 5, 2026 | Option Exercise | — | 19,916 | — | 325,435 | |
TEVA | Eliyahu Sharon Kalif | EVP, Chief Financial Officer | Mar 4, 2026 | Option Exercise | — | 56,763 | — | 305,519 | |
TEVA | Eliyahu Sharon Kalif | EVP, Chief Financial Officer | Mar 3, 2026 | Option Exercise | — | 191,278 | — | 248,756 | |
TEVA | Eliyahu Sharon Kalif | EVP, Chief Financial Officer | Feb 26, 2026 | Sale | $33.64 | 345,810 | $11.6M | 57,478 | |
TEVA | Kalif Eliyahu Sharon | — | Feb 26, 2026 | Proposed Sale | $33.64 | 345,810 | $11.6M | — | |
TEVA | Kalif Eliyahu Sharon | — | Jun 12, 2025 | Proposed Sale | $17.08 | 55,775 | $952.5K | — | |
TEVA | Kalif Eliyahu Sharon | — | Feb 28, 2025 | Proposed Sale | $16.21 | 55,750 | $903.5K | — |